Anna E. Harris
University Park
Nottingham, ENG, United Kingdom
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The functional and therapeutic potential of epitranscriptomics in breast cancer.
Journal: Epigenomics
Published: August 18, 2025
Epigenetic Therapies in Endocrine-Related Cancers: Past Insights and Clinical Progress.
Journal: Cancers
Published: June 24, 2025
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer.
Journal: Molecular oncology
Published: May 08, 2025
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis.
Journal: Discover oncology
Published: March 31, 2025
Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma.
Journal: Life (Basel, Switzerland)
Published: February 13, 2025
Functional and clinical significance of the RNA m6A methyltransferase complex in breast cancer.
Journal: NPJ breast cancer
Published: January 08, 2025
Cardiotoxicity of breast cancer drug treatments.
Journal: Translational oncology
Published: October 21, 2024
Epitranscriptomic mechanisms of androgen signalling and prostate cancer.
Journal: Neoplasia (New York, N.Y.)
Published: May 31, 2024
The role of the ALKBH5 RNA demethylase in invasive breast cancer.
Journal: Discover oncology
Published: January 17, 2024
The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer.
Journal: Frontiers in cell and developmental biology
Published: December 05, 2022
Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer.
Journal: Frontiers in genetics
Published: November 11, 2022
Last Updated: 09/26/2026